キッセイ薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/02 | 3,195 | 3,195 | 3,130 | 3,135 | -20 | -0.6% | 115,500 |
| 2024/02/01 | 3,155 | 3,170 | 3,080 | 3,155 | -10 | -0.3% | 132,500 |
| 2024/01/31 | 3,195 | 3,220 | 3,120 | 3,165 | +15 | +0.5% | 207,100 |
| 2024/01/30 | 3,150 | 3,175 | 3,135 | 3,150 | +25 | +0.8% | 159,400 |
| 2024/01/29 | 3,145 | 3,155 | 3,115 | 3,125 | -5 | -0.2% | 134,800 |
| 2024/01/26 | 3,200 | 3,200 | 3,130 | 3,130 | -70 | -2.2% | 102,500 |
| 2024/01/25 | 3,160 | 3,210 | 3,155 | 3,200 | +25 | +0.8% | 96,300 |
| 2024/01/24 | 3,215 | 3,225 | 3,150 | 3,175 | -45 | -1.4% | 84,200 |
| 2024/01/23 | 3,195 | 3,235 | 3,195 | 3,220 | +45 | +1.4% | 133,800 |
| 2024/01/22 | 3,145 | 3,185 | 3,145 | 3,175 | +35 | +1.1% | 67,100 |
| 2024/01/19 | 3,180 | 3,190 | 3,130 | 3,140 | -65 | -2% | 110,000 |
| 2024/01/18 | 3,205 | 3,225 | 3,190 | 3,205 | ±0 | ±0% | 46,000 |
| 2024/01/17 | 3,250 | 3,275 | 3,200 | 3,205 | -30 | -0.9% | 66,200 |
| 2024/01/16 | 3,285 | 3,300 | 3,230 | 3,235 | -50 | -1.5% | 46,200 |
| 2024/01/15 | 3,220 | 3,290 | 3,220 | 3,285 | +65 | +2% | 52,100 |
| 2024/01/12 | 3,260 | 3,265 | 3,200 | 3,220 | -25 | -0.8% | 62,800 |
| 2024/01/11 | 3,250 | 3,295 | 3,230 | 3,245 | +40 | +1.2% | 80,000 |
| 2024/01/10 | 3,170 | 3,220 | 3,160 | 3,205 | +35 | +1.1% | 55,800 |
| 2024/01/09 | 3,165 | 3,190 | 3,140 | 3,170 | +5 | +0.2% | 49,700 |
| 2024/01/05 | 3,185 | 3,200 | 3,155 | 3,165 | -15 | -0.5% | 77,400 |
| 2024/01/04 | 3,085 | 3,185 | 3,060 | 3,180 | +90 | +2.9% | 72,000 |
| 2023/12/29 | 3,130 | 3,135 | 3,090 | 3,090 | -55 | -1.7% | 82,800 |
| 2023/12/28 | 3,145 | 3,160 | 3,125 | 3,145 | -5 | -0.2% | 32,000 |
| 2023/12/27 | 3,150 | 3,155 | 3,115 | 3,150 | +5 | +0.2% | 53,500 |
| 2023/12/26 | 3,150 | 3,175 | 3,135 | 3,145 | -5 | -0.2% | 86,700 |
| 2023/12/25 | 3,220 | 3,235 | 3,150 | 3,150 | -70 | -2.2% | 63,300 |
| 2023/12/22 | 3,165 | 3,220 | 3,165 | 3,220 | +70 | +2.2% | 72,400 |
| 2023/12/21 | 3,190 | 3,200 | 3,140 | 3,150 | -55 | -1.7% | 105,100 |
| 2023/12/20 | 3,170 | 3,230 | 3,170 | 3,205 | +45 | +1.4% | 97,000 |
| 2023/12/19 | 3,135 | 3,160 | 3,090 | 3,160 | +110 | +3.6% | 115,800 |
| 2023/12/18 | 3,060 | 3,060 | 3,015 | 3,050 | -30 | -1% | 42,100 |
| 2023/12/15 | 3,170 | 3,170 | 3,075 | 3,080 | -95 | -3% | 158,500 |
| 2023/12/14 | 3,150 | 3,190 | 3,150 | 3,175 | +20 | +0.6% | 67,100 |
| 2023/12/13 | 3,160 | 3,190 | 3,110 | 3,155 | -5 | -0.2% | 55,300 |
| 2023/12/12 | 3,130 | 3,185 | 3,130 | 3,160 | +25 | +0.8% | 46,900 |
| 2023/12/11 | 3,130 | 3,155 | 3,115 | 3,135 | +5 | +0.2% | 37,500 |
| 2023/12/08 | 3,125 | 3,145 | 3,115 | 3,130 | +5 | +0.2% | 108,600 |
| 2023/12/07 | 3,125 | 3,180 | 3,115 | 3,125 | -70 | -2.2% | 75,700 |
| 2023/12/06 | 3,145 | 3,195 | 3,135 | 3,195 | +65 | +2.1% | 76,900 |
| 2023/12/05 | 3,135 | 3,165 | 3,120 | 3,130 | -20 | -0.6% | 59,900 |
| 2023/12/04 | 3,095 | 3,155 | 3,090 | 3,150 | +25 | +0.8% | 48,700 |
| 2023/12/01 | 3,095 | 3,135 | 3,095 | 3,125 | +70 | +2.3% | 99,200 |
| 2023/11/30 | 3,045 | 3,055 | 3,015 | 3,055 | +10 | +0.3% | 73,500 |
| 2023/11/29 | 3,045 | 3,060 | 3,025 | 3,045 | ±0 | ±0% | 54,500 |
| 2023/11/28 | 3,040 | 3,055 | 3,015 | 3,045 | +10 | +0.3% | 56,800 |
| 2023/11/27 | 3,070 | 3,080 | 3,025 | 3,035 | -50 | -1.6% | 61,000 |
| 2023/11/24 | 3,090 | 3,095 | 3,055 | 3,085 | +35 | +1.1% | 44,700 |
| 2023/11/22 | 3,025 | 3,055 | 3,020 | 3,050 | +25 | +0.8% | 54,500 |
| 2023/11/21 | 3,000 | 3,040 | 2,995 | 3,025 | +20 | +0.7% | 67,200 |
| 2023/11/20 | 3,065 | 3,070 | 3,000 | 3,005 | -50 | -1.6% | 60,700 |
201～
250
件表示中 / 3588件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| キッセイ薬 | - | +14.5% | -2.3% | - | - | - |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 住友ファーマ | - | +7.5% | - | - | - | - |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 科研薬 | - | +22.8% | +113.0% | - | - | - |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | - | +15.0% | -7.3% | - | - | - |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | - | +52.1% | +23.3% | - | - | - |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
